ConductScience.org, home

Paper21393859

Hunk is required for HER2/neu-induced mammary tumorigenesis.

Yeh ES and 5 others. J Clin Invest, 2011. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Hunk is required for HER2/neu-induced mammary tumorigenesis. Papers, record 21393859. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21393859

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hunk is required for HER2/neu-induced mammary tumorigenesis.
PubMed
Journal
J Clin Invest
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
0.74
iCite
Revised in PubMed
2026-01-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yeh ESElizabeth S
2Yang TWThomas W
3Jung JJJason J
4Gardner HPHeather P
5Cardiff RDRobert D
6Chodosh LALewis A

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gene Expression Regulation, NeoplasticMajor topic
Protein KinasesMajor topic
Protein Serine-Threonine KinasesMajor topic
Erb-b2 Receptor Tyrosine KinasesMajor topic
Animals
Breast Neoplasms
Cell Line, Transformed
Cell Line, Tumor
Female
Humans
Male
Mammary Neoplasms, Animal
Mice
Mice, Transgenic
Microscopy, Fluorescence
Neoplasm Transplantation
Proto-Oncogene Mas

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA093373NCI NIH HHSUnited StatesP30CA093373PubMed and NIHNIH RePORTER
U01 CA141582NCI NIH HHSUnited StatesU01CA141582PubMed and NIHNIH RePORTER
R01 CA098371NCI NIH HHSUnited StatesR01CA098371PubMed and NIHNIH RePORTER
UO1 CA105490NCI NIH HHSUnited StatesU01CA105490PubMed and NIHNIH RePORTER
R01 CA127917NCI NIH HHSUnited StatesR01CA127917PubMed and NIHNIH RePORTER
U01 CA105490NCI NIH HHSUnited StatesU01CA105490PubMed and NIHNIH RePORTER
F32 CA130313NCI NIH HHSUnited StatesF32CA130313PubMed and NIHNIH RePORTER

Download CSV of grants

References98

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110482195Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).Semin Oncol1999https://conductscience.org/library/papers/10482195PubMed
210913383Herceptin (trastuzamab) in advanced breast cancer.Cancer Treat Rev2000https://conductscience.org/library/papers/10913383PubMed
38421674The conserved lysine of the catalytic domain of protein kinases is actively involved in the phosphotransfer reaction and not required for anchoring ATP.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8421674PubMed
416027121Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity.J Biol Chem2005https://conductscience.org/library/papers/16027121PubMed
517890319IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17890319PubMed
618955454Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer.J Clin Oncol2008https://conductscience.org/library/papers/18955454PubMed
715866171AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.Mol Cell2005https://conductscience.org/library/papers/15866171PubMed
87768349Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification.FASEB J1995https://conductscience.org/library/papers/7768349PubMed
919690609A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response.PLoS One2009https://conductscience.org/library/papers/19690609PubMed
1018381417Phosphatase and tensin homologue deleted on chromosome 10 deficiency accelerates tumor induction in a mouse model of ErbB-2 mammary tumorigenesis.Cancer Res2008https://conductscience.org/library/papers/18381417PubMed
118012996Prognostic factors and response to therapy in breast cancer.Cancer Surv1993https://conductscience.org/library/papers/8012996PubMed
1216369543A role for the scaffolding adapter GAB2 in breast cancer.Nat Med2006https://conductscience.org/library/papers/16369543PubMed
1310742152Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets.Nat Med2000https://conductscience.org/library/papers/10742152PubMed
1410662544Cloning and characterization of Hunk, a novel mammalian SNF1-related protein kinase.Genomics2000https://conductscience.org/library/papers/10662544PubMed
1512228201
Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial.
J Clin Oncol2002https://conductscience.org/library/papers/12228201PubMed
1616144086Cloning of short hairpin RNAs for gene knockdown in mammalian cells.Nat Methods2004https://conductscience.org/library/papers/16144086PubMed
1716489017Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity.Cancer Res2006https://conductscience.org/library/papers/16489017PubMed
1811522658ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.Cancer Res2001https://conductscience.org/library/papers/11522658PubMed
193798106Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.Science1987https://conductscience.org/library/papers/3798106PubMed
2011741534C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1.Mol Cell2001https://conductscience.org/library/papers/11741534PubMed

See all 98 referencesDownload CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
40598530Hormonally upregulated neu tumor-associated kinase (HUNK) modulates gastric cancer progression through the regulation of cell homeostasis.Cell Commun Signal2025https://conductscience.org/library/papers/40598530PubMed
40441033Modulating hormonally upregulated neu-associated kinase (HUNK) activity in breast cancer: The development of HUNK inhibitors.J Pharmacol Exp Ther2025https://conductscience.org/library/papers/40441033PubMed
39455282Chronic interferon-stimulated gene transcription promotes oncogene-induced breast cancer.Genes Dev2024https://conductscience.org/library/papers/39455282PubMed
38846083HUNK as a key regulator of tumor-associated macrophages in triple negative breast cancer.Oncoimmunology2024https://conductscience.org/library/papers/38846083PubMed
38307028Identification and characterization of a potent and selective HUNK inhibitor for treatment of HER2+ breast cancer.Cell Chem Biol2024https://conductscience.org/library/papers/38307028PubMed
37193711HUNK inhibits epithelial-mesenchymal transition of CRC via direct phosphorylation of GEF-H1 and activating RhoA/LIMK-1/CFL-1.Cell Death Dis2023https://conductscience.org/library/papers/37193711PubMed
36551828HUNK Gene Alterations in Breast Cancer.Biomedicines2022https://conductscience.org/library/papers/36551828PubMed
33982062PRG2 and AQPEP are misexpressed in fetal membranes in placenta previa and percreta†.Biol Reprod2021https://conductscience.org/library/papers/33982062PubMed
32676513HUNK Signaling in Metastatic Breast Cancer.Oncoscience2020https://conductscience.org/library/papers/32676513PubMed
31597954HUNK phosphorylates EGFR to regulate breast cancer metastasis.Oncogene2020https://conductscience.org/library/papers/31597954PubMed
31438969Integral membrane protein 2A inhibits cell growth in human breast cancer via enhancing autophagy induction.Cell Commun Signal2019https://conductscience.org/library/papers/31438969PubMed
31343992Gene loci associated with insulin secretion in islets from non-diabetic mice.J Clin Invest2019https://conductscience.org/library/papers/31343992PubMed
30599775c-MYB and DMTF1 in Cancer.Cancer Invest2019https://conductscience.org/library/papers/30599775PubMed
30542510Staurosporine, an inhibitor of hormonally up-regulated neu-associated kinase.Oncotarget2018https://conductscience.org/library/papers/30542510PubMed
28189783Hormonally up-regulated neu-associated kinase: A novel target for breast cancer progression.Pharmacol Res2017https://conductscience.org/library/papers/28189783PubMed
27726101Lapatinib resistance in HER2+ cancers: latest findings and new concepts on molecular mechanisms.Tumour Biol2016https://conductscience.org/library/papers/27726101PubMed
27553713Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.Int J Cancer2017https://conductscience.org/library/papers/27553713PubMed
27045589Co-Targeting of JNK and HUNK in Resistant HER2-Positive Breast Cancer.PLoS One2016https://conductscience.org/library/papers/27045589PubMed
26899482TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion.Nat Commun2016https://conductscience.org/library/papers/26899482PubMed
26496021Bisphenol A Disrupts HNF4α-Regulated Gene Networks Linking to Prostate Preneoplasia and Immune Disruption in Noble Rats.Endocrinology2016https://conductscience.org/library/papers/26496021PubMed

See all 25 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
HUNK30811PubTator's text mininghttps://conductscience.org/library/genes/30811NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21393859

GET https://conductscience.org/api/papers/v1/21393859/references?page=2